Molecular Insight into Retinal Diseases: 2nd Edition

Dear Colleagues,

Retinal vascular occlusion, normal tension glaucoma, diabetic retinopathy, and age-related macular degeneration (AMD) are associated with retinal ischemia and can threaten vision. The incidence rates of these diseases are as follows: 0.0018% for central retinal artery occlusion (CRAO); 4% for primary open-angle glaucoma (in urban areas); 2.9% for sight-threatening diabetic retinopathy (type 2 diabetes); and 0.36% for AMD (age ≥40).

The aim of this Special Issue is to evaluate the protective effects and underlying mechanisms of complementary medicine or therapies against retinal ischemia. Recent advancements in retinal research have addressed several subtopics: neuroprotection in retinal ischemia (e.g., anti-VEGF agents such as faricimab, protectants like modified cerebrolysin, acupuncture, stem cells, gene therapy, and retinal chips); femtosecond-assisted phacovitrectomy; Artisan lenses in IOL dislocation; Artiflex lenses in moderate myopia; exozymes in Harada disease with associated dry eye; and comparison of silicon oil versus scleral buckles in capsulotomized pseudophakic eyes with inferior break-induced inferior retinal detachment (RD).

In macular surgery, recent topics include the use of amniotic membranes or ILM flaps in macular holes with or without RD, as well as electrophysiological and pathological evaluations using techniques such as EOG, multifocal ERG, flash ERG, VEP, microperimetry, and OCT-A.

Please note that purely clinical studies are not suitable for submission to International Journal of Molecular Sciences (IJMS). However, clinical or preclinical model studies that incorporate biomolecular experiments are welcome.

Prof. Dr. Hsiaoming Chao
Prof. Dr. Robert Casson
Dr. Hsi-Kung Kuo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.